Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

about

The role of inflammation in the development of epilepsy.

P2860

Q55265934-2BBAC2C7-3DE3-47C3-A256-206B6299B55B

P2860

Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Item

http://www.wikidata.org/entity/Q41962057

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Epilepsy and behavioral change ...... acid decarboxylase antibodies.

@en

type

Item

label

Epilepsy and behavioral change ...... acid decarboxylase antibodies.

@en

prefLabel

Epilepsy and behavioral change ...... acid decarboxylase antibodies.

@en

P1476

Epilepsy and behavioral change ...... acid decarboxylase antibodies.

@en

P2093

Bruria Ben-Zeev

http://www.w3.org/2001/XMLSchema#string

Dalit Modan-Moses

http://www.w3.org/2001/XMLSchema#string

Esther Ganelin-Cohen

http://www.w3.org/2001/XMLSchema#string

Hannah Kanety

http://www.w3.org/2001/XMLSchema#string

Rina Hemi

http://www.w3.org/2001/XMLSchema#string

P2860

Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies

Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding.

High titers of autoantibodies to glutamate decarboxylase in type 1 diabetes patients: epitope analysis and inhibition of enzyme activity.

Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

GABAergic mechanisms in epilepsy.

Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions.

Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.

Glutamic acid decarboxylase autoantibodies and neurological disorders.

Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

P304

617-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PEDI.12346

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christiane S Hampe

Dalit Modan-Moses

P577

2015-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26711844

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

4927419

http://www.w3.org/2001/XMLSchema#string

Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

about

P2860

P2860

Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932